Akeso, Inc. (AKESO) income statement

HKSE · Healthcare · Biotechnology · 4,082 employees · CEO Yu Xia

Price: HK$78.90 -3.19%
Market cap: HK$72.7B
Enterprise value: CN¥57.8B
Last report: Q2 '26 filed 2026-06-30
Next report: 2027-03-31

Akeso, Inc. (AKESO) reported revenue of CN¥1.78B for Q2 '26 (+26.2% year on year), operating income of -CN¥279M (-15.6% of revenue) and net income of -CN¥418M. Over the last four quarters revenue was –.

Income statement

Income statement	Q4 '20	Q2 '21	Q4 '21	Q2 '22	Q4 '22	Q2 '23	Q4 '23	Q2 '24	Q4 '24	Q2 '25	Q4 '25	Q2 '26
Revenue	CN¥0	CN¥129M	CN¥97M	CN¥163M	CN¥675M	CN¥3.68B	CN¥849M	CN¥1.02B	CN¥1.1B	CN¥1.41B	CN¥1.62B	CN¥1.78B
Cost of revenue	CN¥1.9M	CN¥1.38M	CN¥31.6M	CN¥28.5M	CN¥74.6M	CN¥78.6M	CN¥58.9M	CN¥87.1M	CN¥202M	CN¥291M	CN¥355M	CN¥459M
Gross profit	-CN¥1.9M	CN¥127M	CN¥65.4M	CN¥135M	CN¥600M	CN¥3.6B	CN¥790M	CN¥938M	CN¥897M	CN¥1.12B	CN¥1.26B	CN¥1.32B
Research & development	CN¥528M	CN¥564M	CN¥559M	CN¥595M	CN¥728M	CN¥575M	CN¥679M	CN¥594M	CN¥593M	CN¥731M	CN¥830M	CN¥773M
Sales & marketing	CN¥0	CN¥0	CN¥179M	CN¥150M	CN¥403M	CN¥442M	CN¥448M	CN¥516M	CN¥486M	CN¥670M	CN¥0	CN¥786M
General & administrative	CN¥154M	CN¥72.5M	CN¥171M	CN¥92.7M	CN¥106M	CN¥100M	CN¥99.7M	CN¥99.7M	CN¥104M	CN¥134M	CN¥0	CN¥170M
Other operating expenses	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	-CN¥127M
Operating expenses	CN¥630M	CN¥585M	CN¥881M	CN¥819M	CN¥1.32B	CN¥1.15B	CN¥1.23B	CN¥1.21B	CN¥1.18B	CN¥1.54B	CN¥1.74B	CN¥1.6B
Operating income	-CN¥683M	-CN¥506M	-CN¥858M	-CN¥747M	-CN¥791M	CN¥2.32B	-CN¥437M	-CN¥272M	-CN¥286M	-CN¥414M	-CN¥481M	-CN¥279M
Interest income	CN¥29.3M	CN¥8.52M	CN¥3.89M	CN¥7.34M	CN¥8.43M	CN¥40.5M	CN¥40.2M	CN¥111M	CN¥110M	CN¥67M	CN¥149M	CN¥147M
Interest expense	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥66.5M	CN¥62.4M
Other non-operating income (gains on investments, FX ...)	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥160M	CN¥117M	CN¥110M	CN¥62.1M	CN¥75.2M	CN¥0	CN¥0
Total non-operating income	CN¥81.1M	CN¥60.1M	CN¥45.8M	CN¥55.2M	CN¥60.2M	CN¥8.56M	-CN¥110M	CN¥23.1M	CN¥34M	-CN¥173M	-CN¥62.6M	-CN¥159M
Income before tax	-CN¥602M	-CN¥446M	-CN¥812M	-CN¥692M	-CN¥730M	CN¥2.49B	-CN¥547M	-CN¥249M	-CN¥252M	-CN¥588M	-CN¥544M	-CN¥438M
Income tax	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	-CN¥35.5M	CN¥174K	CN¥0	CN¥0	CN¥385K	CN¥0	CN¥3.3M
Net income	-CN¥504M	-CN¥425M	-CN¥650M	-CN¥630M	-CN¥538M	CN¥2.53B	-CN¥497M	-CN¥239M	-CN¥276M	-CN¥570M	-CN¥534M	-CN¥418M
EPS (basic)	-CN¥0.64	-CN¥0.52	-CN¥0.80	-CN¥0.77	-CN¥0.65	CN¥3.01	-CN¥0.59	-CN¥0.28	-CN¥0.32	-CN¥0.64	-CN¥0.58	-CN¥0.46
EPS (diluted)	-CN¥0.64	-CN¥0.52	-CN¥0.80	-CN¥0.77	-CN¥0.64	CN¥3.01	-CN¥0.59	-CN¥0.28	-CN¥0.32	-CN¥0.64	-CN¥0.58	-CN¥0.46
Shares (basic, weighted)	789M	815M	817M	814M	831M	838M	837M	845M	857M	891M	911M	919M
Shares (diluted, weighted)	789M	815M	817M	814M	836M	838M	838M	845M	857M	895M	911M	919M
Depreciation & amortization	CN¥11.9M	CN¥19M	CN¥39.6M	CN¥45.5M	CN¥60.5M	CN¥66.7M	CN¥75.7M	CN¥88.9M	CN¥103M	CN¥124M	CN¥137M	CN¥163M
EBITDA	-CN¥671M	-CN¥487M	-CN¥818M	-CN¥702M	-CN¥730M	CN¥2.39B	-CN¥478M	-CN¥293M	-CN¥245M	-CN¥366M	-CN¥367M	-CN¥413M

Income statement	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	CN¥2.83M	CN¥70.9M	CN¥0	CN¥226M	CN¥838M	CN¥4.53B	CN¥2.12B	CN¥2.98B
Cost of revenue	CN¥0	CN¥0	CN¥1.9M	CN¥30.2M	CN¥103M	CN¥133M	CN¥289M	CN¥635M
Gross profit	CN¥2.83M	CN¥70.9M	-CN¥1.9M	CN¥195M	CN¥735M	CN¥4.39B	CN¥1.83B	CN¥2.34B
Research & development	CN¥161M	CN¥308M	CN¥769M	CN¥1.12B	CN¥1.32B	CN¥1.25B	CN¥1.19B	CN¥1.53B
Sales & marketing	CN¥0	CN¥0	CN¥0	CN¥179M	CN¥553M	CN¥890M	CN¥1B	CN¥0
General & administrative	CN¥6.76M	CN¥55.4M	CN¥253M	CN¥244M	CN¥199M	CN¥200M	CN¥204M	CN¥0
Other operating expenses	CN¥585K	CN¥53M	CN¥0	-CN¥79.7M	CN¥0	CN¥0	-CN¥54.3M	CN¥3
Operating expenses	CN¥168M	CN¥417M	CN¥1.02B	CN¥1.47B	CN¥2.07B	CN¥2.34B	CN¥2.34B	CN¥3.22B
Operating income	-CN¥154M	-CN¥293M	-CN¥1.02B	-CN¥1.35B	-CN¥1.34B	CN¥2.04B	-CN¥570M	-CN¥918M
Interest income	CN¥5.62M	CN¥5.22M	CN¥33.5M	CN¥12.4M	CN¥22M	CN¥120M	CN¥206M	CN¥291M
Interest expense	CN¥2.65M	CN¥5.74M	CN¥0	CN¥0	CN¥43.3M	CN¥87M	CN¥68.3M	CN¥128M
Other non-operating income (gains on investments, FX ...)	-CN¥13.9M	CN¥47.8M	CN¥109K	CN¥13.8M	CN¥197M	CN¥14.7M	CN¥172M	CN¥0
Total non-operating income	CN¥11.3M	-CN¥53.5M	-CN¥297M	CN¥92.1M	-CN¥82M	-CN¥102M	CN¥69.3M	-CN¥231M
Income before tax	-CN¥154M	-CN¥346M	-CN¥1.32B	-CN¥1.26B	-CN¥1.42B	CN¥1.94B	-CN¥501M	-CN¥1.11B
Income tax	-CN¥14.3M	-CN¥64.7M	CN¥0	CN¥0	CN¥0	CN¥174K	CN¥0	CN¥0
Net income	-CN¥140M	-CN¥335M	-CN¥1.04B	-CN¥1.07B	-CN¥1.17B	CN¥2.03B	-CN¥515M	-CN¥1.08B
EPS (basic)	-CN¥0.18	-CN¥2.74	-CN¥1.65	-CN¥1.32	-CN¥1.42	CN¥2.42	-CN¥0.60	-CN¥1.20
EPS (diluted)	-CN¥0.18	-CN¥2.74	-CN¥1.65	-CN¥1.32	-CN¥1.42	CN¥2.42	-CN¥0.60	-CN¥1.20
Shares (basic, weighted)	763M	103M	629M	816M	825M	838M	851M	903M
Shares (diluted, weighted)	763M	103M	629M	816M	825M	838M	851M	903M
Depreciation & amortization	CN¥13M	CN¥16.5M	CN¥22.1M	CN¥58.2M	CN¥106M	CN¥143M	CN¥194M	CN¥262M
EBITDA	-CN¥141M	-CN¥324M	-CN¥1B	-CN¥1.31B	-CN¥1.27B	CN¥2.17B	-CN¥536M	-CN¥656M

Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in CNY.

Revenue, operating income and growth

quarterly

Margins

quarterly

Costs as % of revenue

quarterly

The other statements

Balance sheetCash, investments, assets, debt, liabilities and equityOpen Cash flowOperating cash flow, capex, free cash flow, buybacks and dividendsOpen

Sources

Statements, segment revenue, metrics and estimates are standardised from the company's filings.

Data as of 2026-11-02 · Amounts in CNY as reported; price and market cap in HKD.